Safety and preclinical efficacy of aerosol pioglitazone on lung adenoma prevention in A/J mice

Pioglitazone is a PPARγ agonist commonly prescribed for the clinical treatment of diabetes. We sought to expand its use to lung cancer prevention in a benzo[a]pyrene (B[a]P) mouse model with direct lung delivery via inhalation. Initially we conducted inhalational toxicity experiments with 0, 15, 50,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Prev Res (Phila)
Main Authors: Seabloom, Donna E., Galbraith, Arthur R., Haynes, Anna M., Antonides, Jennifer D., Wuertz, Beverly R., Miller, Wendy A., Miller, Kimberly A., Steele, Vernon E., Suen, Chen S., O’Sullivan, M. Gerard, Ondrey, Frank G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5687250/
https://ncbi.nlm.nih.gov/pubmed/27993834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-16-0174
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados